This disclosure relates to a sustained release oral dosage form suitable for twice a day administration comprising a matrix containing a viscosity modifier and coated granules containing hydrocodone. The dosage form can have a release profile such that 6 hours following administration less than about 80 percent of the hydrocodone is released. In addition the dosage form may have alcohol and/or crush resistance.
